Found 11 matching trials
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
PHASE2This study will address the question of whether targeting CMV antigens with...
Location
Children's Hospital Colorado
ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas
PHASE1The purpose of this study is to determine the safety and efficacy of a PEPI...
Location
Duke University Medical Center
DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab
PHASE2Patients with newly diagnosed glioblastoma will be consented following tumo...
Status
Active Not Recruiting
Location
Duke University Medical Center
Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens
PHASE1Newly diagnosed glioblastoma (GBM) patients with complete or partial surgic...
Location
The Preston Robert Tisch Brain Tumor Center at Duke
PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma
PHASE1The primary goal of this prospective clinical trial is to evaluate the safe...
Status
Active Not Recruiting
Location
Duke University Medical Center
PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma
PHASE1This is a multisite, phase I/II clinical trial in children and young adults...
Location
Washington University School of Medicine
Immune Function and Muscle Adaptations to Resistance Exercise in Older Adults
NAThe loss of muscle mass and strength due to aging leads to serious health p...
Location
Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR
Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma
PHASE2This single-arm phase II study will assess the impact of tetanus pre-condit...
Location
Duke University Medical Center
Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I)
PHASE1The standard of care for children with DIPG includes focal radiotherapy (RT...
Location
UF Health Shands Children's Hospital
IDH1 Peptide Vaccine for Recurrent Grade II Glioma
PHASE1Potential subjects with progressive Grade II primary brain tumor that have ...
Location
Duke University Medical Center